Cloning and characterization of human and mouse telomerase RNA gene promoter sequences

被引:62
作者
Zhao, JQ
Hoare, SF
McFarlane, R
Muir, S
Parkinson, EK
Black, DM
Keith, WN
机构
[1] Univ Glasgow, CRC, Beatson Labs, Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland
[2] Beatson Inst Canc Res, Beatson Labs, Glasgow G61 1BD, Lanark, Scotland
关键词
telomerase; gene expression; hTR; terc; gene promoter; gene transcription;
D O I
10.1038/sj.onc.1201892
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Variation in telomerase activity is correlated with cellular senescence and tumour progression. However, although the enzymatic activity of telomerase has been well studied, very little is known about how expression of telomerase genes is regulated in mammalian cells. We have therefore cloned the promoter regions of the human (hTR), and mouse, (terc), telomerase RNA genes in order to identify the regulatory elements controlling telomerase RNA gene transcription, 1.76 kb encompassing the hTR gene promoter region was sequenced, as was 4 kb encompassing the terc promoter. No significant sequence similarity could be detected in comparisons between human and mouse 5'-regions, flanking the transcribed sequences. However, both the human and mouse telomerase RNA genes are within CpG islands and may therefore be under the regulation of DNA methylation. Transient expression of hTR-reporter gene constructs in HeLa and GM847 cells identified the elements responsible for promoter activity are contained in a 231 bp region upstream of the transcriptional start site, Transient expression of terc-reporter gene constructs in Swiss3T3 and A9 cells identified the elements responsible for promoter activity are contained in a 73 bp region upstream of the transcriptional start site. These studies have implications for novel transcription targeted cancer therapies.
引用
收藏
页码:1345 / 1350
页数:6
相关论文
共 48 条
[41]  
SODER AI, 1997, IN RPESS ONCOGENE
[42]   Transcription factors, normal myeloid development, and leukemia [J].
Tenen, DG ;
Hromas, R ;
Licht, JD ;
Zhang, DE .
BLOOD, 1997, 90 (02) :489-519
[43]  
VERTINO PM, 1994, CELL GROWTH DIFFER, V5, P1395
[44]  
WASYLYK C, 1994, ONCOGENE, V9, P3665
[45]   The DNA structures at the ends of eukaryotic chromosomes [J].
Wellinger, RJ ;
Sen, D .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (05) :735-749
[46]  
WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925
[47]  
Wright WE, 1996, DEV GENET, V18, P173
[48]   Life and cancer without telomerase [J].
Zakian, VA .
CELL, 1997, 91 (01) :1-3